-
1 Comment
HLS Therapeutics Inc is currently in a long term downtrend where the price is trading 2.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.3.
HLS Therapeutics Inc's total revenue rose by 18.3% to $16M since the same quarter in the previous year.
Its net income has increased by 40.4% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 1513.1% to $3M since the same quarter in the previous year.
Based on the above factors, HLS Therapeutics Inc gets an overall score of 4/5.
| Exchange | TO |
|---|---|
| CurrencyCode | CAD |
| ISIN | CA40390B1094 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | None |
|---|---|
| PE Ratio | None |
| Beta | 1.03 |
| Target Price | 5.9119 |
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally. The company's lead products include Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds royalty interest in Takeda's Obizur, which is a porcine recombinant Factor VIII for acquired Hemophilia A. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HLS.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
